Study to evaluate the effectiveness of siddha medicine Nilapanai chooranam in treating Vulvo vaginitis

Single centric phase II open clinical trial in kabayoni Rogam ( Vulvo vaginitis ) with the siddha medicine Nilapanai Chooranam - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105715

Enrollment

Registered

2026-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

Intervention1: NILAPANAI CHOORANAM: All the ingredients after purification were dried and grounded separately to powder. The powder was sieved through a white cloth. All these powdered ingredients wer

Eligibility

Inclusion criteria

Inclusion criteria: White discharge per vagina, Pruritus vulva, Lower abdominal pain, Low back pain, Dysuria, Nonspecific leucorrhoea, Positive Gardnerella vaginalis, Candida, Trichomonas infected patients.

Exclusion criteria

Exclusion criteria: Known complaints of Diabetes mellitus, Sexually transmitted disease (Gonorrhoea/Syphilitic Infection/HIV), Vulnerable Populations.

Design outcomes

Primary

Measure	Time frame
The outcome of this treatment will be assessed mainly by reduction in Clinical symptoms. It is also assessed by pre and post treatment reports of vaginal wet smear.Timepoint: 4 Weeks	—

Secondary

Measure	Time frame
The outcome of this treatment will be assessed mainly by reduction in Clinical symptoms. It is also assessed by pre and post treatment reports of vaginal wet smear.Timepoint: 4 Weeks	—

Countries

India

Contacts

Public ContactDr K SUDHAMATHI PUSHPARAJ

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

sudhamathipushparaj@gmail.com9445118473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026